Human monocyte sub-population for treatment of central nervous system injury

摘要

#$%^&*AU2017254830A120171116.pdf#####ABSTRACT A subpopulation of peripheral blood mononuclear cells (PBMCs) that is substantially devoid of CD3' cells, CD19' cells, CD56' cells and optionally of CD16' cells, for use in treatment of CNS injury is provided.